Purdue Pharma Court Trial - Search News

Purdue Pharma, OxyContin and Opioid epidemic

The Washington Post on MSN · 3d

Purdue Pharma owners strike new $6.5 billion deal in opioid case

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.

Hosted on MSN · 2d

Purdue Pharma Agrees To $7 Billion Settlement Over OxyContin's Role In Opioid Crisis

Bankrupt Purdue Pharma LP and its owners have agreed to over $7 billion settlement to resolve lawsuits over OxyContin's role in the opioid epidemic. The deal follows the U.S. Supreme Court’s rejection of a $6 billion agreement last year.

Philadelphia Inquirer · 2d

Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin

The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was rejected by the Supreme Court.

Sackler family, Purdue Pharma boost multistate opioid settlement to $7.4B in new agreement

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

Neomorph, AbbVie strike $1.64 billion deal

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results